We are live on
!
Find out more
WA
Winfield Associates Portfolio holdings
AUM
$276M
1-Year Est. Return
15.18%
This Fund
S&P 500
This Quarter
Est. Return
+7.84%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.9%
10 Year Est. Return
–
AUM
$122M
AUM Growth
–
Cap. Flow
+$118M
Cap. Flow
% of AUM
96.75%
Top 10 Holdings %
Top 10 Hldgs %
28.1%
Holding
283
New
283
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$5.75M |
| 2 |
Apple
AAPL
|
+$4.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$3.83M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.4M |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$3.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.59% |
| 2 | Technology | 8.3% |
| 3 | Energy | 8.3% |
| 4 | Industrials | 8.28% |
| 5 | Consumer Discretionary | 6.17% |
Similar funds
SCM
ANRIA
PCA
LCP
FPOC
PWP
BHTS
KWP
Winfield Associates's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Winfield Associates, which disclosed 283 positions worth $122M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is iShares Biotechnology ETF: 81,030 shares worth $6.13M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, followed by Technology and Energy.
- Winfield Associates's largest Q4 2013 buy was iShares Biotechnology ETF: 81,030 shares worth $6.13M.
- Winfield Associates's ten largest holdings make up 28% of its $122M portfolio in Q4 2013.
- Winfield Associates disclosed 283 positions in Q4 2013, its first 13F filing on record.
Based on Winfield Associates's 13F filing for Q4 2013, filed 17 Mar 2014.